Fulcrum Therapeutics Correlations

FULC Stock

USD 7.10 0.55 7.19%

The current 90-days correlation between Fulcrum Therapeutics and RAPT Therapeutics is 0.22 (i.e., Modest diversification). The correlation of Fulcrum Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Fulcrum Therapeutics Correlation With Market

Average diversification

The correlation between Fulcrum Therapeutics and DJI is 0.17 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Fulcrum Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Fulcrum Stock

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fulcrum Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Fulcrum Stock refer to our How to Trade Fulcrum Stock guide.

Moving together with Fulcrum Stock

0.76	PFE	Pfizer Inc	Pair Corr
0.73	KMDA	Kamada	Pair Corr
0.7	NTNX	Nutanix	Pair Corr
0.9	CAT	Caterpillar	Pair Corr
0.9	AXP	American Express	Pair Corr
0.92	BA	Boeing Earnings Call This Week	Pair Corr
0.93	CSCO	Cisco Systems	Pair Corr
0.89	JPM	JPMorgan Chase Sell-off Trend	Pair Corr
0.96	MSFT	Microsoft Aggressive Push	Pair Corr
0.8	DD	Dupont De Nemours Earnings Call This Week	Pair Corr
0.96	GE	GE Aerospace Earnings Call Today	Pair Corr
0.88	IBM	International Business Earnings Call Tomorrow	Pair Corr
0.88	MMM	3M Company	Pair Corr

Moving against Fulcrum Stock

0.58	MSB	Mesabi Trust	Pair Corr
0.4	GTOR	Ggtoor Inc	Pair Corr

Related Correlations Analysis

	RAPT	MIRM	BYSI	STOK	PHAT
RAPT		0.67	0.41	0.75	0.59	RAPT
MIRM	0.67		0.78	0.92	0.84	MIRM
BYSI	0.41	0.78		0.76	0.87	BYSI
STOK	0.75	0.92	0.76		0.85	STOK
PHAT	0.59	0.84	0.87	0.85		PHAT
	RAPT	MIRM	BYSI	STOK	PHAT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

There is a big difference between Fulcrum Stock performing well and Fulcrum Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Fulcrum Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
RAPT	5.99	1.04	0.15	1.17	5.87	(7.19)	16.30	(11.08)	64.07
MIRM	1.55	0.34	0.16	0.50	1.75	(1.79)	3.87	(2.27)	14.67
BYSI	5.18	1.10	0.13	(0.86)	5.71	(6.26)	13.57	(10.58)	47.73
STOK	2.54	0.66	0.17	1.07	2.76	(2.70)	7.08	(5.67)	21.76
PHAT	6.43	1.36	0.20	1.72	6.03	(8.41)	10.95	(10.96)	99.31

Fulcrum Therapeutics Corporate Management

Rudolf MD	Founder	Profile
CPA CMA	Chief Officer	Profile
Jeffrey Jacobs	Chief Officer	Profile
Mel Hayes	Executive Experience	Profile
Paul Bruno	Senior Development	Profile
Bryan Stuart	CEO Pres	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC